Vinorelbine in the therapy of advanced breast cancer
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F99%3A00000123" target="_blank" >RIV/00209805:_____/99:00000123 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Vinorelbine in the therapy of advanced breast cancer
Original language description
In group of 72 patients was vinorelbine combined with docetaxol, 5-fluorouracil, doxorubicin, mitomycine. In our patients we administered 317 cycles of chemotherapy with vinorelbine. The best response rate was achieved in those patients who treated withthe vinorelbine and docetaxel regimen.
Czech name
—
Czech description
—
Classification
Type
D - Article in proceedings
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
—
Continuities
Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
1999
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Article name in the collection
20th OECI Annual Scientific Meeting associated with 23rd Brno Days of Oncology and 13th Conference of Nurses
ISBN
—
ISSN
—
e-ISSN
—
Number of pages
1
Pages from-to
—
Publisher name
Masarykův onkologický ústav
Place of publication
Brno
Event location
—
Event date
—
Type of event by nationality
—
UT code for WoS article
—